HPHA.DE
Heidelberg Pharma AG
Price:
3.45
EUR
Volume:
14,365
Germany | Biotechnology
HPHA.DE Gross Margin
As of 2025-05-29, the Gross Margin of Heidelberg Pharma AG (HPHA.DE) is 74%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
HPHA.DE Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-11-30 | 74% |
| 2023-11-30 | 67% |
| 2022-11-30 | 74.7% |
| 2021-11-30 | -169.3% |
| 2020-11-30 | 34% |
| 2019-11-30 | 48.9% |
| 2018-11-30 | 39.8% |
| 2017-11-30 | 49.7% |
| 2016-11-30 | 40.6% |
| 2015-11-30 | 50.1% |
HPHA.DE Gross Margin - Peers Comparison